205 related articles for article (PubMed ID: 9272161)
21. Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth disease.
Hahn AF; Bolton CF; White CM; Brown WF; Tuuha SE; Tan CC; Ainsworth PJ
Ann N Y Acad Sci; 1999 Sep; 883():366-82. PubMed ID: 10586261
[TBL] [Abstract][Full Text] [Related]
22. Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity.
Young P; Grote K; Kuhlenbäumer G; Debus O; Kurlemann H; Halfter H; Funke H; Ringelstein EB; Stögbauer F
J Neurol; 2001 May; 248(5):410-5. PubMed ID: 11437164
[TBL] [Abstract][Full Text] [Related]
23. X-linked dominant Charcot-Marie-Tooth disease: nerve biopsies allow morphological evaluation and detection of connexin32 mutations (Arg15Trp, Arg22Gln).
Senderek J; Bergmann C; Quasthoff S; Ramaekers VT; Schröder JM
Acta Neuropathol; 1998 May; 95(5):443-9. PubMed ID: 9600589
[TBL] [Abstract][Full Text] [Related]
24. Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease.
Abrams CK; Bennett MV; Verselis VK; Bargiello TA
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3980-4. PubMed ID: 11891346
[TBL] [Abstract][Full Text] [Related]
25. Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease.
Abrams CK; Oh S; Ri Y; Bargiello TA
Brain Res Brain Res Rev; 2000 Apr; 32(1):203-14. PubMed ID: 10751671
[TBL] [Abstract][Full Text] [Related]
26. MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families.
Braathen GJ; Sand JC; Lobato A; Høyer H; Russell MB
BMC Med Genet; 2010 Mar; 11():48. PubMed ID: 20350294
[TBL] [Abstract][Full Text] [Related]
27. Three novel mutations in the gap junction beta 1 (GJB1) gene coding region identified in Charcot-Marie-Tooth patients of Greek origin: T55I, R164Q, V120E. Mutation in brief no 236. Online.
Karadimas C; Panas M; Chronopoulou P; Avramopoulos D; Vassilopoulos D
Hum Mutat; 1999; 13(4):339. PubMed ID: 10220155
[TBL] [Abstract][Full Text] [Related]
28. Point mutation associated with X-linked dominant Charcot-Marie-Tooth disease impairs the P2 promoter activity of human connexin-32 gene.
Wang HL; Wu T; Chang WT; Li AH; Chen MS; Wu CY; Fang W
Brain Res Mol Brain Res; 2000 May; 78(1-2):146-53. PubMed ID: 10891594
[TBL] [Abstract][Full Text] [Related]
29. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease.
Ressot C; Bruzzone R
Brain Res Brain Res Rev; 2000 Apr; 32(1):192-202. PubMed ID: 10751670
[TBL] [Abstract][Full Text] [Related]
30. X-linked Charcot-Marie-Tooth disease: molecular analysis of interfamilial variability.
Niewiadomski LA; Kelly TE
Am J Med Genet; 1996 Dec; 66(2):175-8. PubMed ID: 8958325
[TBL] [Abstract][Full Text] [Related]
31. Connexin mutations in X-linked Charcot-Marie-Tooth disease.
Bergoffen J; Scherer SS; Wang S; Scott MO; Bone LJ; Paul DL; Chen K; Lensch MW; Chance PF; Fischbeck KH
Science; 1993 Dec; 262(5142):2039-42. PubMed ID: 8266101
[TBL] [Abstract][Full Text] [Related]
32. Four novel connexin 32 mutations in X-linked Charcot-Marie-Tooth disease. Phenotypic variability and central nervous system involvement.
Karadima G; Koutsis G; Raftopoulou M; Floroskufi P; Karletidi KM; Panas M
J Neurol Sci; 2014 Jun; 341(1-2):158-61. PubMed ID: 24768312
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1).
Fairweather N; Bell C; Cochrane S; Chelly J; Wang S; Mostacciuolo ML; Monaco AP; Haites NE
Hum Mol Genet; 1994 Jan; 3(1):29-34. PubMed ID: 8162049
[TBL] [Abstract][Full Text] [Related]
34. Clinical and electrophysiological studies of a family with probable X-linked dominant Charcot-Marie-Tooth neuropathy and ptosis.
Wu T; Wang HL; Chu CC; Yu JM; Chen JY; Huang CC
Chang Gung Med J; 2004 Jul; 27(7):489-500. PubMed ID: 15508871
[TBL] [Abstract][Full Text] [Related]
35. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
36. Mutation testing in Charcot-Marie-Tooth neuropathy.
Nicholson GA
Ann N Y Acad Sci; 1999 Sep; 883():383-8. PubMed ID: 10586262
[TBL] [Abstract][Full Text] [Related]
37. A point mutation in the human connexin32 promoter P2 does not correlate with X-linked dominant Charcot-Marie-Tooth neuropathy in Germany.
Bergmann C; Schröder JM; Rudnik-Schöneborn S; Zerres K; Senderek J
Brain Res Mol Brain Res; 2001 Mar; 88(1-2):183-5. PubMed ID: 11295246
[TBL] [Abstract][Full Text] [Related]
38. New connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease.
Bone LJ; Dahl N; Lensch MW; Chance PF; Kelly T; Le Guern E; Magi S; Parry G; Shapiro H; Wang S
Neurology; 1995 Oct; 45(10):1863-6. PubMed ID: 7477983
[TBL] [Abstract][Full Text] [Related]
39. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.
Omori Y; Mesnil M; Yamasaki H
Mol Biol Cell; 1996 Jun; 7(6):907-16. PubMed ID: 8816997
[TBL] [Abstract][Full Text] [Related]
40. A new de novo mutation of the connexin-32 gene in a patient with X-linked Charcot-Marie-Tooth type 1 disease.
Di Iorio G; Cappa V; Ciccodicola A; Sampaolo S; Ammendola A; Sanges G; Giugliano R; D'Urso M
Neurol Sci; 2000 Apr; 21(2):109-12. PubMed ID: 10938190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
